Status:
RECRUITING
Embolization of Middle Meningeal Artery in Chronic Subdural Hematoma
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Conditions:
Chronic Subdural Hematomas
Eligibility:
All Genders
50-90 years
Phase:
NA
Brief Summary
Chronic subdural hematoma (cSDH) is a common neurological affliction which affects mostly frail and elderly patients. Surgical evacuation by using burr hole craniostomy (BHC) is the most frequently us...
Detailed Description
Chronic subdural hematoma A chronic subdural hematoma (cSDH) is a bleeding of the bridging veins between the dura mater and the arachnoid. Subdural hematomas are one of the most common forms of hemor...
Eligibility Criteria
Inclusion
- · CT-confirmed diagnosis of chronic Subdural Hematoma;
- Primary surgical treatment based on clinical symptoms (progressive neurological deficits).
Exclusion
- · Significant contraindication to angiography (eg. allergy for contrast);
- Structural causes for subdural hemorrhage, e.g. arachnoid cysts, cortical vascular malformations and a history of cranial surgery in the previous 365 days;
- Inability to obtain informed consent from the patient or legal representative (when the patient has a depressed level of consciousness), including language barrier;
- Monocular blindness on contralateral side of the hematoma;
Key Trial Info
Start Date :
December 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT04511572
Start Date
December 10 2020
End Date
October 1 2025
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam university medical Centers
Amsterdam, Netherlands, 1100 DD